MARKET

BFRG

BFRG

BULLFROG AI HLDGS INC
NASDAQ
0.8500
-0.0220
-2.52%
Opening 15:58 01/06 EST
OPEN
0.9000
PREV CLOSE
0.8720
HIGH
0.9000
LOW
0.8053
VOLUME
23.61M
TURNOVER
--
52 WEEK HIGH
4.840
52 WEEK LOW
0.8036
MARKET CAP
9.70M
P/E (TTM)
-1.2255
1D
5D
1M
3M
1Y
5Y
1D
Bullfrog AI highlights presentation of data from bfLEAP
TipRanks · 11h ago
BullFrog AI To Highlight bfLEAP Pancreatic Cancer Trial Data With ~3x Survival Gain At ASCO GI 2026
Benzinga · 11h ago
BullFrog AI Platform Triples Survival Rates in Pancreatic Cancer Patient Subgroups
Reuters · 11h ago
BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer
Barchart · 17h ago
Weekly Report: what happened at BFRG last week (1229-0102)?
Weekly Report · 1d ago
Catalyst Watch: AI spotlight at CES, Versant starts trading, and the December jobs report
Seeking Alpha · 4d ago
BullFrog AI Highlights Commercialization Progress in Shareholder Update
TipRanks · 12/30/2025 22:30
BullFrog AI Holdings Inc. Publishes 2025 Shareholder Letter
Reuters · 12/30/2025 22:01
More
About BFRG
Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence/machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.

Webull offers Bullfrog AI Holdings Inc stock information, including NASDAQ: BFRG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRG stock methods without spending real money on the virtual paper trading platform.